Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Observational

Relationship Between Balance, Arm Function and Body Awareness in People With Stroke

NCT07652710 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-06-18
Last updated
2026-09-30

Condition(s) studied

Chronic Stroke Patient

Study summary

Stroke is one of the leading causes of long-term disability worldwide and is frequently associated with impairments in balance, upper extremity function, and body awareness. These impairments may negatively affect independence in activities of daily living and overall quality of life. Although previous studies have investigated the relationships between balance and upper extremity function after stroke, body awareness has received relatively limited attention.

The aim of this observational cross-sectional study is to investigate the relationship between balance, upper extremity skills, and body awareness in individuals with chronic stroke. Fifty-three individuals with chronic stroke will be recruited from the Department of Physical Medicine and Rehabilitation at Baskent University Hospital.

Balance will be assessed using the Berg Balance Scale and the Tetrax computerized posturography system. Upper extremity motor impairment and functional performance will be evaluated using the Fugl-Meyer Upper Extremity Assessment and the Wolf Motor Function Test. Body awareness will be assessed using the Body Awareness Questionnaire. Additional assessments will include lower extremity motor function, muscle tone, cognitive status, shoulder range of motion, and upper extremity reaction time.

The study is expected to provide a better understanding of the relationships among balance, upper extremity function, and body awareness in individuals with chronic stroke. The findings may contribute to the development of individualized rehabilitation strategies and improve clinical assessment approaches in stroke rehabilitation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Individuals who experienced a cerebrovascular event at least 6 months previously * Individuals between 18 and 75 years of age * Individuals who have experienced stroke for the first time * Individuals with shoulder, elbow, wrist, and finger muscle tone graded as 2 or 3 according to the Modified Ashworth Scale (MAS) * Individuals scoring 24 points or higher on the Standardized Mini Mental State Examination * Individuals with at least 120° of shoulder range of motion * Individuals who are able to walk independently or with a walking aid Exclusion Criteria: * Presence of communication problems such as difficulties in reading, writing, or speaking * Botulinum toxin injection within the last 3 months * Presence of hemispatial neglect syndrome * Presence of ataxia due to posterior circulation ischemia * Bilateral involvement (bilateral hemiparesis) * Having received physiotherapy within the last 6 months * Presence of orthopedic problems such as shoulder subluxation, shoulder pain, contracture of the hand and wrist * History of upper extremity or thoracic surgery * Presence of stroke-related visual impairments (hemianopia) * Presence of color blindness * Use of antiepileptic medication * History of convulsions

Primary outcome measure(s)

  • Berg Balance Scale Score — Baseline (single assessment)
    To assess balance performance, the Berg Balance Scale (BBS) will be used. The scale consists of 14 functional tasks including sitting to standing, transfers, turning, reaching forward, picking up an object from the floor, and standing on one leg. Each item is scored from 0 to 4. Total scores range from 0 to 56, with higher scores indicating better balance performance.
  • Tetrax Fall Index — Baseline (single assessment)
    To assess fall risk the Tetrax Computerized Posturography System will be used. Measurements will be performed under eight different sensory conditions. The Fall Index ranges from 0 to 100, with higher scores indicating a greater risk of falling.
  • Eyes Open Stability Index — Baseline (single assessment)
    To assess postural stability under eyes-open conditions, the Tetrax Computerized Posturography System will be used. The Stability Index obtained during the normal standing position with eyes open will be recorded. Higher values indicate poorer postural stability.
  • Eyes Closed Stability Index — Baseline (single assessment)
    To assess postural stability without visual input, participants will stand on the Tetrax Computerized Posturography System with their eyes closed. The Stability Index obtained during this condition will be recorded. Higher values indicate poorer postural stability.
  • Weight Distribution Index — Baseline (single assessment)
    To assess weight distribution during standing, the Tetrax Computerized Posturography System will be used. The Weight Distribution Index will be recorded. Higher values indicate greater asymmetry in weight distribution between the supporting surfaces.
  • Fugl-Meyer Upper Extremity Assessment Score — Baseline (single assessment)
    To assess upper extremity motor impairment, the Fugl-Meyer Upper Extremity Assessment will be used. The scale evaluates reflex activity, voluntary movement, coordination, and speed. Scores range from 0 to 66, with higher scores indicating better upper extremity motor function.
  • Wolf Motor Function Test Functional Ability Score — Baseline (single assessment)
    Upper extremity functional ability will be assessed using the Functional Ability Scale of the Wolf Motor Function Test (WMFT). Fifteen functional tasks will be evaluated and scored on a scale from 0 to 5, with higher scores indicating better upper extremity function.
  • Wolf Motor Function Test Performance Time — Baseline (single assessment)
    Upper extremity motor performance will be assessed using the Wolf Motor Function Test (WMFT). The average time required to complete the 15 functional tasks will be recorded in seconds. Shorter completion times indicate better upper extremity performance.
  • Body Awareness Questionnaire Score — Baseline (single assessment)
    To assess body awareness, the Body Awareness Questionnaire will be used. The questionnaire consists of 18 items evaluating awareness of bodily processes and reactions. Total scores range from 18 to 126, with higher scores indicating greater body awareness.

Trial sites (1)

FacilityCityRegionStatus
Baskent University Hospital Ankara Ankara
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07652710 on ClinicalTrials.gov ↗ ← All trials in Turkey